Ceva Santé Animale is the world's fifth-largest animal health company, generating approximately $2.1 billion in 2025 turnover. Headquartered in Libourne, France, operating in 110 countries through 7,200 employees, 21 R&D centers, and 32 production sites — the largest privately held player in the global animal health top tier.
This report provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs.
Strategic priorities include Asia-Pacific expansion (regional HQ relocated to Shanghai 2026), DNA vaccine collaboration with Touchlight, and companion animal franchise strengthening. Strengths include leadership in poultry vaccines, strong R&D for a private company, and patient capital from the Temasek-led group. Risks include scale disadvantage versus public top-four, geographic concentration, and limited financial transparency.
Topics Covered
• Corporate Overview and History
• Strategic Directions and 2026-2030 Priorities
• Financial Performance and Segment Breakdown
• SWOT Analysis
• Business Segment Analysis
• Technology and Innovation Pipeline
• M&A, Partnerships and Licensing Activity
• Competitive Positioning Against Top 10 Peers
• Strategic Conclusions and Outlook
Table of Contents
1. Executive Summary
2. Company Overview
3. Strategic Directions
4. Financial Performance
5. SWOT Analysis
6. Business Segment Analysis
7. Technology and Innovation
8. M&A and Partnerships
9. Competitive Positioning
10. Strategic Conclusions
11. Appendix
List of Tables
Table 1. Ceva Santé Animale — Consolidated Revenue and Operating Income 2021-2025
Table 2. Ceva Santé Animale — Revenue by Segment 2023-2025
Table 3. Ceva Santé Animale — Revenue by Geography 2023-2025
Table 4. Ceva Santé Animale — Top Products by Revenue 2025
Table 5. Ceva Santé Animale — R&D Investment and Pipeline 2023-2025
Table 6. Ceva Santé Animale — M&A and Licensing Activity 2023-2026
Table 7. Ceva Santé Animale — SWOT Analysis Summary
Table 8. Ceva Santé Animale — Competitive Positioning vs. Top 10 Peers
Table 9. Ceva Santé Animale — Capital Allocation 2023-2025
Table 10. Ceva Santé Animale — 2026 Guidance and Strategic Milestones
